Suzanne Bujara

Contributing Writer https://www.infectiousdiseaseadvisor.com

Suzanne Bujara is a medical writer with more than 20 years of experience. She writes for continuing medical education and public health programs. She has a BA in linguistics from Douglass College, Rutgers, The State University of New Jersey and an MBA from Rutgers Business School. Before starting her freelance business in 2016, Suzanne wrote for Medscape Education, myCME, praxis.md, and Medical Economics magazine. To learn more about Suzanne, visit www.suzannebujara.com and www.linkedin.com/in/suzannebujara.

All articles by Suzanne Bujara

GI Illness

What Role Does Bariatric Surgery Play in Altering the Gut Microbiome?

Suzanne Bujara

September 17, 2019

Researchers are still elucidating how weight loss after bariatric surgery affects the gut microbiome and overall health.

Pneumonia

Bacterial Pneumonia-Complicating Influenza: Risks, Morbidity, and Mortality

Suzanne Bujara

January 23, 2019

Diagnosing coinfection in pneumonia can be challenging because of timing of the sample collection and false-negative results when the viruses replicate in the lower respiratory tract.

Mother-breastfeeds-baby-girl_G_478167511

HIV/AIDS Advisor

Mothers Infected With HIV: How to Advise Mothers Who Wish to Breastfeed

Suzanne Bujara

July 30, 2018

Some advocates say that women with undetectable viral loads should be able to breastfeed after thorough consultation with their clinicians.

Sepsis

Prognostic Biomarkers to Guide Antibiotic Therapy in Critically Ill Patients

Suzanne Bujara

June 27, 2018

Proadrenomedullin and procalcitonin have demonstrated superiority to C-reactive protein for predicting mortality and guiding antimicrobial therapy in critically ill patients with fever.

liver affected by cirrhosis and hepatitis

Hepatitis Advisor

Etiology of Acute Liver Failure Can Yield Surprising Findings

Suzanne Bujara

June 8, 2018

Before the advent of potent antiviral agents, liver transplantation was the only treatment option for patients with hepatitis and a poor prognosis; antiretrovirals can now provide a potentially curative approach.

Emerging Diseases

Platform Manufacturing May Speed Pandemic Vaccine Development

Suzanne Bujara

June 1, 2018

With the advent of platform manufacturing technology, vaccines can be developed quickly to stop the spread of outbreaks.

Pharmacogenomics will help combat the opioid crisis

HIV/AIDS

Why Treating Major Depressive Disorder Improves Outcomes in HIV

Suzanne Bujara

May 2, 2018

Mental health problems are 1 of the most important reasons for failing to engage in long-term control of HIV.

Hepatitis Advisor

Patients With Rheumatic Diseases Need to Be Monitored for HBV Reactivation

Suzanne Bujara

May 1, 2018

Clinicians need to monitor reactivation of the hepatitis B virus in patients with rheumatic diseases by testing for elevation of liver enzymes and HBV DNA levels.

Hepatitis Advisor

Closing the Gap in Managing Viral Hepatitis Infections in Refugees and Immigrants

Suzanne Bujara

April 6, 2018

To meet the goals of the World Health Organization for reducing new infections and decreasing deaths associated with hepatitis B and C virus by 2030, people on the margins of society will need to be tested and treated, including refugees and migrants from endemic regions, as well as people who inject drugs.

Next post in Skin Infections